Teleflex Incorporated TFX
156.33 USD +1.03 (+0.66%)
At closeNov 11, 2026, 4:00 PM EST
156.33 0.00 0.00%
After hours · Nov 11, 4:00 PM ET
153.99 Day range 156.47
100.18 52-week range 156.67
- YTD
- +28.10%
- 1 year
- +39.26%
News
businesswire.com Teleflex to Present at the Jefferies Global Healthcare Conference in London WAYNE, Pa.--(BUSINESS WIRE)--Management of Teleflex Incorporated (NYSE: TFX) is scheduled to speak at the Jefferies Global Healthcare Conference in London on Wednesday, November 18, 2026, at 12:00…
benzinga.com Truist Securities Maintains Hold on Teleflex, Raises Price Target to $167 Truist Securities analyst Ravi Misra maintains Teleflex (NYSE:TFX) with a Hold and raises the price target from $142 to $167.
defenseworld.net Teleflex Q3 Earnings Call Highlights Teleflex (NYSE: TFX) raised its 2026 adjusted earnings outlook after reporting higher third-quarter earnings and a return to growth in its Interventional business, although the company said a planned…
marketbeat.com Teleflex Q3 Earnings Call Highlights Teleflex NYSE: TFX raised its 2026 adjusted earnings outlook after reporting higher third-quarter earnings and a return to growth in its Interventional business, although the company said a planned…
benzinga.com RBC Capital Maintains Outperform on Teleflex, Raises Price Target to $175 RBC Capital analyst Kendall Au maintains Teleflex (NYSE:TFX) with a Outperform and raises the price target from $155 to $175.- benzinga.com Wells Fargo Maintains Equal-Weight on Teleflex, Raises Price Target to $167 Wells Fargo analyst Larry Biegelsen maintains Teleflex (NYSE:TFX) with a Equal-Weight and raises the price target from $138 to $167.
seekingalpha.com Teleflex Incorporated (TFX) Q3 2026 Earnings Call Transcript Teleflex Incorporated (TFX) Q3 2026 Earnings Call Transcript
zacks.com Teleflex (TFX) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates While the top- and bottom-line numbers for Teleflex (TFX) give a sense of how the business performed in the quarter ended September 2026, it could be worth looking at how some of its key metrics…
zacks.com Teleflex (TFX) Q3 Earnings Surpass Estimates Teleflex (TFX) came out with quarterly earnings of $2.63 per share, beating the Zacks Consensus Estimate of $1.92 per share. This compares to earnings of $3.67 per share a year ago.
benzinga.com Teleflex Q3 2026 Earnings Call Transcript Teleflex (NYSE:TFX) reported third-quarter financial results on Thursday. The transcript from the company’s third-quarter earnings call has been provided below.This transcript is brought to you by…
businesswire.com Teleflex Announces Quarterly Dividend WAYNE, Pa.--(BUSINESS WIRE)--Teleflex Incorporated (NYSE: TFX) announced today that its Board of Directors declared a quarterly cash dividend of thirty-four cents ($0.34) per share of common stock.…
benzinga.com Teleflex Raises FY2026 Adj EPS Guidance from $6.90-$7.20 to $7.50-$7.75 vs $7.22 Est; Lowers FY2026 Sales Guidance from $2.260B-$2.280B to $2.256B-$2.276B vs $2.269B Est Teleflex (NYSE:TFX) raises FY2026 Adj EPS guidance from $6.90-$7.20 to $7.50-$7.75 vs $7.22 analyst estimate. Lowers FY2026 sales outlook from $2.260 billion-$2.280 billion to $2.256 billion-$2.276…
benzinga.com Teleflex Q3 Adj. EPS $2.63 Beats $1.90 Estimate, Sales $567.800M Beat $566.772M Estimate Teleflex (NYSE:TFX) reported quarterly earnings of $2.63 per share which beat the analyst consensus estimate of $1.90 by 38.42 percent. The company reported quarterly sales of $567.800 million which…
businesswire.com Teleflex Reports Third Quarter Financial Results and Full Year 2026 Outlook WAYNE, Pa.--(BUSINESS WIRE)--Teleflex Incorporated (NYSE: TFX) (the “Company”) today announced financial results for the third quarter ended September 30, 2026. Third quarter 2026 continuing…
benzinga.com Teleflex Receives FDA Breakthrough Device Designation For Its Freesolve Resorbable Magnesium Scaffold For Percutaneous Coronary Intervention To qualify for a BDD, device technology must address an unmet clinical need and show that it has the potential to provide for more effective treatment of life-threatening diseases or irreversibly…
businesswire.com Teleflex Announces FDA Breakthrough Device Designation for Freesolve™ Resorbable Magnesium Scaffold WAYNE, Pa.--(BUSINESS WIRE)--Teleflex Incorporated (NYSE: TFX), a leading global provider of medical technologies, today announced that the U.S. Food and Drug Administration (FDA) has granted…
businesswire.com Teleflex Announces Third Quarter 2026 Earnings Conference Call Information WAYNE, Pa.--(BUSINESS WIRE)--Teleflex Incorporated (NYSE:TFX) will host a conference call to discuss its third quarter financial results and provide an operational update at 8:00 a.m. Eastern Time on…
benzinga.com Truist Securities Maintains Hold on Teleflex, Lowers Price Target to $142 Truist Securities analyst Richard Newitter maintains Teleflex (NYSE:TFX) with a Hold and lowers the price target from $150 to $142.
benzinga.com Teleflex Completes Patient Enrollment In BIOMAG-LL Clinical Study, Evaluating Freesolve RMS In 35 mm And 40 mm Lengths For Treatment Of De Novo Coronary Lesions Up To 38 mm 102 patients enrolled across 14 European centers to assess safety and clinical performance of 35 mm and 40 mm Freesolve™ Resorbable Magnesium Scaffolds in long coronary lesionsTeleflex Incorporated…
businesswire.com Enrollment Completed in BIOMAG™-LL Clinical Study Evaluating Longer Lengths for Freesolve™ Resorbable Magnesium Scaffold WAYNE, Pa.--(BUSINESS WIRE)--Teleflex Incorporated (NYSE: TFX), a leading global provider of medical technologies, today announced the successful completion of patient enrollment in the BIOMAG™-LL…
benzinga.com Full Transcript: Teleflex Q2 2026 Earnings Call Teleflex (NYSE:TFX) reported second-quarter financial results on Thursday. The transcript from the company's second-quarter earnings call has been provided below. This transcript is brought to you by…
zacks.com TFX or SONVY: Which Is the Better Value Stock Right Now? Investors interested in Medical - Instruments stocks are likely familiar with Teleflex (TFX) and SONOVA HOLDING (SONVY). But which of these two stocks offers value investors a better bang for their…
zacks.com Is It Prudent to Add Teleflex Stock to Your Portfolio Now? TFX's Vascular growth, Asia expansion and improved leverage support the outlook, but tariffs, input costs and margin pressure remain key risks.
benzinga.com This Nice Analyst Turns Bullish; Here Are Top 3 Upgrades For Wednesday Wall Street analysts upgraded Grocery Outlet, NICE and Pinnacle Financial Partners; targets are $15, $150 and $118, respectively.
benzinga.com This Staar Surgical Analyst Turns Bullish; Here Are Top 5 Upgrades For Tuesday Analysts upgraded STAA, NFLX, SFIX, with ratings moving toward Buy or Neutral and mixed price-target changes.
businesswire.com Teleflex Announces Latest Peer-Reviewed Study Demonstrates a Significant Reduction in CLABSI Risk with Arrowg+ard™ Technology WAYNE, Pa.--(BUSINESS WIRE)--Teleflex Incorporated (NYSE: TFX), a leading global provider of medical technologies, today announced the publication of its latest peer-reviewed study in the American…
zacks.com Teleflex (TFX) Soars 4.4%: Is Further Upside Left in the Stock? Teleflex (TFX) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions could translate into further price increase in…
benzinga.com Nasdaq 100 Sinks, Oil Rallies as Trump Rejects Iran's Hormuz Plan: Stock Market Today Stocks slipped at midday Monday as oil surged and yields hit a 19-year high after Trump rejected Iran's Hormuz plan; MongoDB tumbled 18%.
benzinga.com This First Solar Analyst Is No Longer Bearish; Here Are Top 5 Upgrades For Monday Analysts upgraded Royal Caribbean, Park Hotels, First Solar, Teleflex and CF Industries, with several receiving higher price targets.
247wallst.com Here Are Monday’s Top Wall Street Analyst Research Calls: Applied Digital, Autodesk, Datadog, First Solar, L3Harris Technologies, PepsiCo, Roblox, Snowflake, TeraWulf and More Wall Street analysts are making bold moves as the third quarter closes, with major calls hitting PepsiCo, Roblox, Snowflake, and a Bitcoin infrastructure stock carrying a price target that will turn…- benzinga.com B of A Securities Upgrades Teleflex to Buy, Raises Price Target to $158 B of A Securities analyst Craig Bijou upgrades Teleflex (NYSE:TFX) from Neutral to Buy and raises the price target from $145 to $158.
zacks.com Here's Why Teleflex (TFX) is a Strong Value Stock Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
zacks.com 5 Low P/B Stocks That Offer Attractive Value and Growth TFX, CNC, ENS, ROCK and FAF stand out among five low P/B stocks offering attractive value and promising growth prospects.
defenseworld.net VIRGINIA RETIREMENT SYSTEMS ET Al Acquires New Shares in Teleflex Incorporated $TFX VIRGINIA RETIREMENT SYSTEMS ET Al acquired a new position in Teleflex Incorporated (NYSE: TFX) in the second quarter, according to its most recent filing with the Securities and Exchange Commission…
defenseworld.net Teleflex Incorporated $TFX Shares Sold by Amundi Amundi lowered its position in Teleflex Incorporated (NYSE: TFX) by 70.7% during the undefined quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm…
benzinga.com Nvidia To Rally More Than 8%? Here Are 10 Top Analyst Forecasts For Tuesday Top Wall Street analysts upgraded and raised price targets for FLNC, DT, NVDA, SNOW, TFX, COIN, and EXPE. See how other analysts view these stocks.- benzinga.com Needham Maintains Buy on Teleflex, Raises Price Target to $170 Needham analyst Mike Matson maintains Teleflex (NYSE:TFX) with a Buy and raises the price target from $159 to $170.
- benzinga.com UBS Maintains Neutral on Teleflex, Raises Price Target to $158 UBS analyst Patrick Wood maintains Teleflex (NYSE:TFX) with a Neutral and raises the price target from $145 to $158.
benzinga.com Truist Securities Maintains Hold on Teleflex, Raises Price Target to $150 Truist Securities analyst Ravi Misra maintains Teleflex (NYSE:TFX) with a Hold and raises the price target from $143 to $150.
benzinga.com Piper Sandler Reiterates Overweight on Teleflex, Raises Price Target to $169 Piper Sandler analyst Jason Bednar reiterates Teleflex (NYSE:TFX) with a Overweight and raises the price target from $160 to $169.- benzinga.com Teleflex Raises FY2026 Adj EPS Guidance from $6.25-$6.55 to $6.90-$7.20 vs $6.68 Est; Lowers FY2026 Sales Guidance from $2.280B-$2.300B to $2.260B-$2.280B vs $2.287B Est Teleflex (NYSE:TFX) raises FY2026 Adj EPS guidance from $6.25-$6.55 to $6.90-$7.20 vs $6.68 analyst estimate. Lowers FY2026 sales outlook from $2.280 billion-$2.300 billion to $2.260 billion-$2.280…
- benzinga.com Teleflex Q2 Adj. EPS $1.76 Beats $1.28 Estimate, Sales $570.332M Beat $559.596M Estimate Teleflex (NYSE:TFX) reported quarterly earnings of $1.76 per share which beat the analyst consensus estimate of $1.28 by 37.5 percent. This is a 52.82 percent decrease over earnings of $3.73 per…
- benzinga.com Needham Maintains Buy on Teleflex, Raises Price Target to $159 Needham analyst Mike Matson maintains Teleflex (NYSE:TFX) with a Buy and raises the price target from $147 to $159.
- benzinga.com UBS Initiates Coverage On Teleflex with Neutral Rating, Announces Price Target of $145 UBS analyst Patrick Wood initiates coverage on Teleflex (NYSE:TFX) with a Neutral rating and announces Price Target of $145.
- benzinga.com Teleflex Awarded National Premier Contract for Central Venous, Arterial and Intraosseous Access Devices Teleflex Incorporated (NYSE:TFX) has been awarded a national group purchasing agreement for central venous access products with Premier, Inc. Effective July 1, 2026, the new agreement allows Premier…
benzinga.com Mizuho Maintains Neutral on Teleflex, Raises Price Target to $145 Mizuho analyst Anthony Petrone maintains Teleflex (NYSE:TFX) with a Neutral and raises the price target from $140 to $145.- benzinga.com BMO Capital Initiates Coverage On Teleflex with Outperform Rating, Announces Price Target of $159 BMO Capital analyst Vik Chopra initiates coverage on Teleflex (NYSE:TFX) with a Outperform rating and announces Price Target of $159.
- benzinga.com Teleflex Starts Enrollment For Its BIOMAG‑IIII Study Evaluating The Freesolve Resorbable Magnesium Scaffold Dr. Itsik Ben-Dor, MedStar Health in Washington, D.C., is the first implanter in the United States (U.S.) in the IDE trial of Freesolve™ RMS. Designed as a pivotal trial to support future regulatory…
- benzinga.com Teleflex Presents 4‑Yr Follow‑Up Data From First-in-Human BIOMAG-I Clinical Study At EuroPCR Conference Persistently Low Target Lesion Failure and No New Cardiac-Related EventTeleflex Incorporated (NYSE:TFX), a leading global provider of medical technologies, today announced the four‑year follow‑up…
- benzinga.com Piper Sandler Upgrades Teleflex to Overweight, Raises Price Target to $160 Piper Sandler analyst Matt O'Brien upgrades Teleflex (NYSE:TFX) from Neutral to Overweight and raises the price target from $140 to $160.